CDC Advisory Panel: J&J Vaccine Benefits Outweigh Risks

Published on July 22, 2021

Even after reports of a neurological disorder in the six weeks after inoculation with Johnson & Johnson’s COVID-19 vaccine, the benefits of its use outweigh risks, according to an advisory panel of the U.S. Centers for Disease Control and Prevention.

Read Full Article (External Site)